Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Long-haul flights are often the necessary first step to an incredible adventure, but let’s be honest: the journey itself is rarely glamorous. Whether you’re flying overnight or crossing multiple time ...